Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of neurodegenerative diseases through autophagy activity mediated by a synthetic ligand or arginylated BIP binding to the P62 ZZ domain

Prevention and treatment of neurodegenerative diseases through autophagy activity mediated by a synthetic ligand or arginylated BIP binding to the P62 ZZ domain

US Patent 10391067 · Granted Aug 27, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

P62 ligand compound, and composition for preventing, ameliorating or treating pr2025
Cargo delivery system and composition comprising the same2025
Wafer-level design and wiring pattern for a semiconductor package2025
Semiconductor package comprising first molding layer and second molding layer wi2025
Semiconductor package and method for manufacturing the same2024
Data driving circuit, display device including the same, and method of driving t2024
AUTOTAC chimeric compound, and composition for preventing, ameliorating or treat2024
Semiconductor package and method for manufacturing the same2024
Compound and pharmaceutical composition for preventing or treating obesity or me2024
P62 ligand compound, and composition for preventing, ameliorating or treating pr2024
Benzyloxy pyridine derivatives and uses thereof2023
Gate driver and display device including the same2023